High-confidence spatial biology and liquid biopsy
Seattle, WA
Joined July 2016
- Tweets965
- Following140
- Followers371
- Likes147
How well do circulating tumor cells (CTCs) reflect the biology of a patient’s tumor? 🤔
A new study from UW provides compelling evidence that CTC protein expression can reflect key tumor characteristics in patients with advanced prostate cancer.
onlinelibrary.wiley.com/doi/…
Live from Biomarkers, CDx & Precision Medicine Europe 2026!
Come see how Orion™ supports high-plex spatial proteomics for precision therapeutics programs – visit us at Booth #47.
#BIOMEU2026 #BiomarkersEurope2026
Great conversations around spatial proteomics for translational and clinical research at #ESSB2026!
Thank you to all who stopped by the RareCyte booth!
#ESSB #SpatialBiology
Learn how to translate your research question into a custom spatial biomarker panel.
Next week, join a short webinar focused on designing panels for the Orion™ spatial proteomics platform.
✅ See a live demo of the new Panel Designer tool
👉 Register: rarecyte.com/webinar-2026.10…
Live from #BIOMUS2026 in San Diego!
Swing by the RareCyte booth this afternoon to explore how the Orion spatial proteomics platform helps advance biomarker development from translational research through clinical trials.
View conference info: rarecyte.com/events-2026.09.…
Live from #JCA2026 in Kyoto, Japan!
Stop by Yamato's booth E-21 to explore the Orion spatial proteomics platform.
☑️Attend the luncheon seminar today at 12:15!
Spatial Proteomics: Unlocking New Insights into Cancer Biology
More details: rarecyte.com/events-2026.09.…
@yamato_kagaku
At #BIOMUS2026? Don’t miss Dr. Richard van Krieken’s presentation today at 2:55 PM on how high-plex spatial proteomics can generate actionable insights for clinical trials.
Presentation details: rarecyte.com/events-2026.09.…
#BiomarkersUS #SpatialBiology
The challenge: turning spatial proteomics insights into clinically actionable results.
🔎 Here's how three oncology researchers are doing it with Orion™ spatial proteomics.
Read the blog ➡️ rarecyte.com/blog-2026-06-09…
#SpatialBiology #MultiplexIF #SpatialProteomics
Join us for a 30-minute live session focused on how to translate a biological research question into a custom spatial biomarker panel on the Orion spatial proteomics platform.
Plus, see a demo of the new Orion Panel Designer tool.
Register here: rarecyte.com/webinar-2026.10…
Attending #ESSB in Barcelona? Visit RareCyte at booth #18 to explore how researchers use the Orion spatial proteomics platform to advance biomarker development from translational research through clinical trials.
See event details: rarecyte.com/events-2026.09.…
#ESSB26 #ESSB2026
Heading to #BiomarkersUS in San Diego? 🌴 Attend this presentation to hear how high-plex spatial proteomics is being applied in clinical trials.
📅 Sept 23 | 2:55-3:20pm
🗣️ Richard van Krieken, PhD, Navigate BioPharma Services
See presentation details ➡️rarecyte.com/events-2026.09.…
Great conversations at our Orion seminar at the The @UBC this week!
Thank you to UBC Mapcore for hosting us!
We’re thrilled to keep the momentum around spatial proteomics going and support future projects.
#SpatialProteomics #SpatialBiology #OrionSpatial
What distinguishes the immune microenvironment of a tumor that responds to treatment?
In phase 1/2 trial of Copanlisib + nivolumab in microsatellite-stable CRC, Orion provided subcellular imaging of 18 immune-focused markers.
Read publication ➡️ nature.com/articles/s41467-0…
2M+ babies are stillborn each year, yet many maternity care tools haven’t changed in decades.
We are proud to be part of @WellcomeLeap's In Utero program, an initiative with the goal of developing scalable solutions to reduce stillbirth rates by 50%.
Can high-plex spatial proteomics deliver IHC-quality data?
Harvard and BWH researchers showed that 16- to 18-plex Orion panels produced staining patterns comparable to conventional IHC—and enabled diagnostic-quality H&E on the same tissue section.
nature.com/articles/s43018-0…
Spatial proteomics provides critical insights into therapeutic response, but clinical research requires more than multiplex depth alone.
🎬 In this on-demand webinar, learn how Navigate BioPharma Services validated a 17-plex panel for clinical trials. ➡️rarecyte.com/webinar-spatial…
Panel development can be a bottleneck in spatial proteomics.
That's not the case with Orion.
✅ 500+ validated antibody conjugates across 200+ biomarkers, all proven to work in multiplex under the same AR condition
+ easily add custom biomarkers
➡️ rarecyte.com/orion-panels.ht…
Dr. Tanjina Kader discusses her ovarian cancer research at Harvard Medical School and how her team maps spatial proteomics and chromosomal changes on the same tissue section.
#BreastCancer #SpatialProteomics
#ASCO2026 poster utilizing the CyteFinder® Rare Cell Detection platform shows strong concordance of CTC Androgen Receptor and Synaptophysin expression via liquid biopsy with tissue defined neuroendocrine differentiation in prostate cancer.
View poster ➡️ rarecyte.com/posters.html
